Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disrupting Insulin and IGF Receptor Function in Cancer

International Journal of Molecular Sciences(2021)10.3390/ijms22020555Source: DataRank Database

Disrupting Insulin and IGF Receptor Function in Cancer is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.06)OA: goldTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Douglas Yee ORCID,Jingran Cao

Live enrichment

PubMed:33429867 PMC:PMC7827299 OpenAlex:https://openalex.org/W3119105383

National Institutes of Health

Grant: R01CA237000

National Institutes of Health

Grant: P30-CA077598

NCI NIH HHS

Grant: R01 CA251600

National Institutes of Health

Grant: 5P30CA077598-08

Cancer Center Support Grant P30 CA77598-06

FWCI

6.06

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/22/2/555/pdf?version=1610545848

publisherhttps://www.mdpi.com/1422-0067/22/2/555/pdf?version=1610545848

publisherhttps://www.mdpi.com/1422-0067/22/2/555/pdf

journalhttps://doi.org/10.3390/ijms22020555

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33429867

Fields of Study

Growth Hormone and Insulin-like Growth FactorsMetabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism0301 basic medicine0303 health sciences03 medical and health sciencesBreast NeoplasmsCell ProliferationCell SurvivalFemaleHumansInsulinMolecular Targeted TherapyReceptor, IGF Type 1Somatomedins

MeSH Terms

Breast NeoplasmsCell SurvivalFemaleHumansInsulinSomatomedinsReceptor, IGF Type 1Cell ProliferationMolecular Targeted Therapy

Keywords

Insulin-like growth factor 1 receptorInsulin-like growth factorInsulin-Like Growth Factor ReceptorReceptor tyrosine kinaseCancerReceptorTyrosine kinaseInsulin receptorCancer researchInsulinBlocking (statistics)Signal transductionMedicineMonoclonal antibodyGrowth factorCancer cellBiologyEndocrinologyInternal medicineImmunologyCell biologyAntibodyInsulin resistanceComputer scienceInsulin-like Growth FactorsType I Igf ReceptorCell SurvivalBreast NeoplasmsReviewReceptor, IGF Type 1SomatomedinsHumansFemaleMolecular Targeted TherapyCell Proliferation

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 7: 7. Clean energySDG 0: Good health and well-being

Disrupting Insulin and IGF Receptor Function in Cancer

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)